Literature DB >> 14744481

Starch acetate as a tablet matrix for sustained drug release.

Seppo Pohja1, Eero Suihko, Mika Vidgren, Petteri Paronen, Jarkko Ketolainen.   

Abstract

The aim of this study was to investigate the effect of a high degree on substitution (DS) on starch acetate (SA) and SA concentration on tablet properties. SAs with a DS of 2.6 and 3.0 were used as matrix formers with propranolol hydrochloride (PH) as a model drug. The SA-3.0 powder had better compactibility than the SA-2.6 powder. A decrease in SA concentration decreased compactibility of PH/SA blended powders when compared to neat SA powders. In general, drug release was considerably slower from SA-3.0 matrices than from SA-2.6 matrices. Also, a decrease in SA concentration increased the drug release rate. Water penetration into 80% (w/w) SA-3.0 matrices was incomplete during 24-h dissolution tests. Diffusion path length increased with time and PH was released by Fickian diffusion. However, all other PH/SA tablets were completely hydrated during dissolution tests. Macroscopic cracks were formed during dissolution, which increased area available for Fickian diffusion and resulted in slow attenuation of the drug release rate. Crack formation, not been reported earlier, must be taken into account in order to understand drug release from SA matrices.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14744481     DOI: 10.1016/j.jconrel.2003.09.017

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  2 in total

1.  A novel method for the preparation of biodegradable microspheres for protein drug delivery.

Authors:  R Pareta; M J Edirisinghe
Journal:  J R Soc Interface       Date:  2006-08-22       Impact factor: 4.118

2.  Ultrasound transmission technique as a potential tool for physical evaluation of monolithic matrix tablets.

Authors:  M A Hakulinen; J Pajander; J Leskinen; J Ketolainen; B van Veen; K Niinimäki; K Pirskanen; A Poso; R Lappalainen
Journal:  AAPS PharmSciTech       Date:  2008-01-09       Impact factor: 3.246

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.